Visual analysis on clinical randomized controlled trial of fire needle based on VOSviewer and CiteSpace

To analyze the research hotspots, frontiers and trends of fire needle clinical randomized controlled trial (RCT) literature in the past 10 years by using bibliometrics and knowledge mapping methods. Six Chinese and English databases including CNKI, Wanfang, VIP, SinoMed, PubMed and Web of Science (...

Full description

Saved in:
Bibliographic Details
Published inZhōngguó zhēnjiǔ Vol. 44; no. 2; p. 231
Main Authors Song, Yuqiang, Shen, Linbo, Fu, Yuanbo, Li, Bin, Sun, Jingqing, Sun, Sanfeng, Sun, Jie, Li, Baijie, Yu, Han, Ni, Yutong, Li, Qingdai, Han, Peng
Format Journal Article
LanguageEnglish
Published China 12.02.2024
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:To analyze the research hotspots, frontiers and trends of fire needle clinical randomized controlled trial (RCT) literature in the past 10 years by using bibliometrics and knowledge mapping methods. Six Chinese and English databases including CNKI, Wanfang, VIP, SinoMed, PubMed and Web of Science ( WOS ) were searched for RCT research literature on fire needle. CiteSpace V6.1.R6 and VOSviewer V1.6.18 software were used to analyze the cooperation network, keyword co-occurrence, keyword clustering, keyword timeline, keyword emergence, etc., and to draw a visual knowledge map. A total of 1 973 Chinese articles and 3 English articles were included. The top three institutions that publish articles were Guangzhou University of CM, Heilongjiang University of CM and Beijing Hospital of TCM Affiliated to Capital Medical University. The fire needle was often combined with acupuncture, cupping and bloodletting therapy in the treatment of acne, vitiligo, lumbar disc herniation, herpes zoster, stroke sequelae, facial paralysis, knee osteoarthritis and so on. The research frontiers included the combined application of fire needle and other therapies, clinical mechanism research and efficacy evaluation index research. In the future, we should expand the dominant diseases, optimize the research design, strengthen the cooperation between the teams, and carry out high-level clinical research.
ISSN:0255-2930
DOI:10.13703/j.0255-2930.20230321-0004